| n = 11 | % | |
| Therapeutic regimen | ||
| Azathioprine+prednisone | 4 | 36.36 |
| Azathioprine+hydroxychloroquine+prednisone | 2 | 18.18 |
| Mycophenolate mofetil+prednisone | 2 | 18.18 |
| Mycophenolate mofetil+ hydroxychloroquine+prednisone | 1 | 9.09 |
| Hydroxychloroquine+prednisone | 2 | 18.18 |
| Anti-dsDNA (ELISA) positive | 5 | 45.45 |
| Disease manifestations | ||
| Joint | 4 | 36.36 |
| Rash | 3 | 27.27 |
| Serositis | 0 | 0 |
| CNS involvement | 1 | 9.09 |
| Active lupus nephritis | 0 | 0 |
| Haematological | 0 | 0 |
| Vasculitis | 2 | 18.18 |
| Reduced complement levels | 2 | 18.18 |